GEIGER COUNTER LIMITED
GCL | IL
Overview
Corporate Details
- ISIN(s):
- GB00B15FW330 (+1 more)
- LEI:
- 549300O6PWGLLYV1QX57
- Country:
- Jersey
- Address:
- Ordnance House, JE4 8PW St Helier
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Genedrive PLC develops and commercializes easy-to-use, point-of-care pharmacogenetic tests for improved clinical outcomes. Our tests, such as the CYP2C19 ID Kit and MT-RNR1 ID Kit, are designed for rapid, time-critical settings.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for GEIGER COUNTER LIMITED.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-15 13:41 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-15 11:50 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-08-14 13:05 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-14 09:58 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-08-13 15:36 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-13 11:43 |
Transaction in Own Shares
Share Buyback
|
English | 10.5 KB | |
| 2025-08-12 16:23 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-12 09:50 |
Transaction in Own Shares
Share Buyback
|
English | 10.6 KB | |
| 2025-08-11 10:30 |
Transaction in Own Shares
Share Buyback
|
English | 10.6 KB | |
| 2025-08-08 18:10 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-08 08:00 |
Post-Annual General Meeting Information
Results of General Meeting
|
English | 15.4 KB | |
| 2025-08-07 16:04 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-08-07 10:58 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.2 KB | |
| 2025-08-07 10:54 |
Transaction in Own Shares
Share Buyback
|
English | 10.5 KB | |
| 2025-08-05 16:13 |
Net Asset Value
Net Asset Value(s)
|
English | 11.8 KB |
Automate Your Workflow. Get a real-time feed of all GEIGER COUNTER LIMITED filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GEIGER COUNTER LIMITED via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX | |
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX |